We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.95%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$61.1B
AUM Growth
+$4.73B
(+8.4%)
Cap. Flow
+$390M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
17.66%
Holding
2,331
New
154
Increased
918
Reduced
1,058
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.6% |
| 2 | Consumer Discretionary | 14.64% |
| 3 | Healthcare | 14.47% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Staples | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
WesBanco
WSBC
$4.05B
| $800K | ﹤0.01% |
22,182
+13,847
| +166% | +$456K |
|
|
SMAR
1652
DELISTED
Smartsheet Inc.
SMAR
| $798K | ﹤0.01% |
12,635
+7,500
| +146% | +$525K |
|
1653
Goldgroup Mining Inc.
GORO
$184M
| $797K | ﹤0.01% |
301,805
+263,334
| +685% | +$740K |
|
|
SAGE
1654
DELISTED
Sage Therapeutics
SAGE
| $796K | ﹤0.01% |
10,641
+7,091
| +200% | +$581K |
|
1655
El Pollo Loco
LOCO
$452M
| $787K | ﹤0.01% |
48,846
+3,195
| +7% | +$61K |
|
1656
Protagonist Therapeutics
PTGX
$9.6B
| $787K | ﹤0.01% |
30,387
+6,964
| +30% | +$176K |
|
|
SI
1657
DELISTED
Silvergate Capital Corporation
SI
| $786K | ﹤0.01% |
+5,531
| New | +$656K |
|
1658
AMN Healthcare
AMN
$1.28B
| $784K | ﹤0.01% |
10,635
-9,999
| -48% | -$743K |
|
|
CMD
1659
DELISTED
Cantel Medical Corporation
CMD
| $783K | ﹤0.01% |
9,860
-39,904
| -80% | -$3.12M |
|
1660
CytomX Therapeutics
CTMX
$752M
| $781K | ﹤0.01% |
101,008
-22,921
| -18% | -$181K |
|
1661
National Vision
EYE
$1.77B
| $775K | ﹤0.01% |
17,691
+42
| +0.2% | +$2K |
|
|
MDRX
1662
DELISTED
Veradigm Inc. Common Stock
MDRX
| $774K | ﹤0.01% |
51,544
+39,599
| +332% | +$634K |
|
1663
OraSure Technologies
OSUR
$268M
| $773K | ﹤0.01% |
66,244
-10,129
| -13% | -$124K |
|
|
FLNA
1664
Filana Therapeutics
FLNA
$46.9M
| $770K | ﹤0.01% |
17,122
-10,775
| -39% | -$424K |
|
1665
Gates Industrial Corporation Ltd.
GTES
$7.2B
| $769K | ﹤0.01% |
48,123
+12,558
| +35% | +$194K |
|
1666
Wabash National
WNC
$505M
| $765K | ﹤0.01% |
+40,691
| New | +$720K |
|
1667
Home BancShares
HOMB
$6.22B
| $764K | ﹤0.01% |
28,250
+6,224
| +28% | +$150K |
|
|
UCB
1668
United Community Banks
UCB
$4.36B
| $764K | ﹤0.01% |
22,401
+4,867
| +28% | +$160K |
|
1669
Columbus McKinnon
CMCO
$564M
| $762K | ﹤0.01% |
14,440
-10,097
| -41% | -$482K |
|
1670
CRA International
CRAI
$1.06B
| $762K | ﹤0.01% |
10,204
-8,359
| -45% | -$508K |
|
|
EVBG
1671
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $761K | ﹤0.01% |
6,425
-1,450
| -18% | -$204K |
|
1672
Exponent
EXPO
$3.25B
| $759K | ﹤0.01% |
7,784
-9,729
| -56% | -$913K |
|
1673
St. Joe Company
JOE
$3.89B
| $758K | ﹤0.01% |
17,660
+2,478
| +16% | +$118K |
|
|
DSPG
1674
DELISTED
DSP Group Inc
DSPG
| $758K | ﹤0.01% |
53,174
+31,777
| +149% | +$508K |
|
1675
AZZ Inc
AZZ
$4.6B
| $757K | ﹤0.01% |
15,036
-9,564
| -39% | -$484K |
|
Similar funds
VGA
AQR Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, AQR Capital Management held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AQR Capital Management's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- AQR Capital Management added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- AQR Capital Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- AQR Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- AQR Capital Management's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- AQR Capital Management opened 154 new positions and closed 154 in Q1 2021.
- AQR Capital Management's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.